Mr. Speaker, I am honoured to have the opportunity to speak about Bill C-224. This is an important bill that impacts millions of Canadians who rely on natural health products as part of their daily health and wellness routines, and who want to know that the products they are using and consuming are safe.
I think all of us recognize that this bill has some ideas worth exploring. Our government is always open to ideas that help Canadian businesses thrive and ensure that Canadians have access to safe, effective natural health products. In fact, one of our new government's top priorities was to remove burdensome red tape in regulation. We have seen this promise in action in the natural health product sector. Our government heard from natural health product companies that they were finding that some new regulations were too onerous or did not do what they set out to do. In response, we paused some of these regulations and limited the scope of others.
Canada's natural health product industry is a huge part of the economy. We want to make sure that these companies can thrive, but we also want to make sure that Canadians can trust that the natural health products they rely on are safe, and that what they say on the label is what is actually in them. After all, the term “natural health products” encompasses a wide range of products, and one only needs to look at the Health Canada recall page to see that. Sometimes mistakes are made. There can be mislabeled products or undeclared ingredients. In one extreme case last year, a range of multivitamins and supplements had to be recalled across Canada because they contained metal fibres. These recalls are rare, but they show how even seemingly safe products that are authorized and widely used can still have some risks.
That is what makes some regulatory oversight so important. Having food and drug safety regulations that ensure that the products on store shelves are safe, effective and of high quality helps Canadian consumers and Canadian companies alike. These regulations build trust and confidence in the system. Consumers trust that the products on store shelves are what they say they are, while businesses get to operate on a level playing field. It also makes Canada a more attractive destination for companies looking to expand, because they know that we have a regulatory system in place that maintains some of the highest food and drug safety standards in the world.
An unintended consequence of Bill C-224 is that, rather than simply reducing the regulatory burden on natural health product companies, it could make people less certain about the products they are using.
Under the current laws and regulations, the Minister of Health has a number of important powers. They can order a product recall. They can require changes to labels or packaging. They can request additional information about a product when they suspect the product poses a serious risk to human health. They can issue fines against companies that refuse to take unsafe products off the shelf. These are all important tools to protect consumers, and the way it is currently written, the bill would remove these tools altogether.
I know that the bill's sponsor, the member for Ponoka—Didsbury, is a long-time advocate for natural health products. During the previous Parliament, he introduced the forerunner of this bill, Bill C-368, which had many of the same provisions.
I will pause here to note that one important difference between Bill C-368 and Bill C-224 is that the current bill does not exempt nicotine products from the Food and Drugs Act, which is a significant improvement. Both bills are a considerable attempt to help natural health product companies continue to grow and thrive. This is a goal all of us share.
It is certainly a goal of our new government. It is why we have been working closely with our natural health product industry stakeholders as part of our red tape review to streamline and reduce unnecessary regulatory burden. Thanks to the red tape review, Health Canada is shifting to a risk-based approach to oversight that will reduce pre-market requirements for natural health products, while shifting direct oversight and resources to higher-risk areas. It also put a pause on new labelling requirements and is continuing to work with natural health product companies to address their concerns.
We also recognize that a key part of working with the natural health product industry is flexibility. We cannot just apply a one-size-fits-all regulatory approach. One of the important pieces of legislation passed by the previous government was Bill C-69, which gave the Minister of Health the flexibility to respond to urgent and emerging regulatory challenges as they arise with tailored options and solutions. In a world where both industry and government are constantly facing evolving challenges, this kind of flexibility is essential.
This important work needs to continue, and I think there is room within the current bill to allow it to continue, which is why I look forward to voting for this bill and studying it at the health committee.
However, we also need to make sure there are rules and regulations in place to protect Canadian consumers. When Canadians reach for a product on a store's shelves, they need to have confidence in its safety and trust that the label accurately represents the product. If they do not have that confidence, if they cannot trust the product they are buying, it will hurt the entire natural health products industry and, by extension, our economy.
There is an important balance we need to find, and I hope we can study this bill at committee to make sure it strikes the right balance, one that ensures Canadians can have peace of mind when it comes to the products they buy and that Canadian natural health product companies have the tools they need to grow and thrive.